Generation of Isogenic Controls for In Vitro Disease Modelling of X-Chromosomal Disorders

Stem Cell Rev Rep. 2019 Apr;15(2):276-285. doi: 10.1007/s12015-018-9851-8.

Abstract

Generation of proper controls is crucial in induced pluripotent stem cell (iPSC) studies. X-chromosomal disorders offer the potential to develop isogenic controls due to random X-chromosomal inactivation (XCI). However, the generation of such lines is currently hampered by skewed X-inactivation in fibroblast lines and X-chromosomal reactivation (XCR) after reprogramming. Here we describe a method to generate a pure iPSC population with respect to the specific inactivated X-chromosome (Xi). We used fibroblasts from Rett patients, who all have a causal mutation in the X-linked MeCP2 gene. Pre-sorting these fibroblasts followed by episomal reprogramming, allowed us to overcome skewness in fibroblast lines and to retain the X-chromosomal state, which was unpredictable with lentiviral reprogramming. This means that fibroblast pre-sorting followed by episomal reprogramming can be used to reliably generate iPSC lines with specified X-chromosomal phenotype such as Rett syndrome.

Keywords: Episomal reprogramming; Isogenic control; Rett syndrome; X-chromosome; iPSCs.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cellular Reprogramming*
  • Chromosome Disorders / genetics*
  • Chromosomes, Human, X / genetics*
  • Female
  • Fibroblasts / metabolism
  • Fibroblasts / pathology*
  • Humans
  • In Vitro Techniques
  • Induced Pluripotent Stem Cells / cytology*
  • Induced Pluripotent Stem Cells / metabolism
  • Methyl-CpG-Binding Protein 2 / genetics
  • Mutation
  • Phenotype
  • RNA, Long Noncoding / genetics
  • Rett Syndrome / genetics*
  • Rett Syndrome / pathology
  • X Chromosome Inactivation*

Substances

  • MECP2 protein, human
  • Methyl-CpG-Binding Protein 2
  • RNA, Long Noncoding
  • XIST non-coding RNA